Skip to main content
Top
Published in: Critical Care 6/2013

Open Access 01-12-2013 | Research

High-mobility group box 1 and the receptor for advanced glycation end products contribute to lung injury during Staphylococcus aureus pneumonia

Authors: Ahmed Achouiti, Anne Jan van der Meer, Sandrine Florquin, Huan Yang, Kevin J Tracey, Cornelis van ’t Veer, Alex F de Vos, Tom van der Poll

Published in: Critical Care | Issue 6/2013

Login to get access

Abstract

Introduction

Staphylococcus (S.) aureus has emerged as an important cause of necrotizing pneumonia. Lung injury during S. aureus pneumonia may be enhanced by local release of damage associated molecular patterns such as high-mobility group box 1 (HMGB1). In the current study we sought to determine the functional role of HMGB1 and its receptors, toll-like receptor 4 (TLR4) and the receptor for advanced glycation end products (RAGE), in the injurious host response to S. aureus pneumonia.

Methods

Pneumonia was induced in wild type (Wt), TLR4 deficient (tlr4 −/− ) and RAGE deficient (rage −/− ) mice by intranasal inoculation of 1 × 107 colony-forming units (CFU) of a USA300 S. aureus. In a separate set of experiments, Wt mice were injected intraperitoneally with a monoclonal anti-HMGB1 antibody or an isotype matched control antibody immediately before and every 24 hours after intranasal infection of S. aureus. Mice were sacrificed at 6, 24, 48 or 72 hours after infection for harvesting of blood and organs.

Results

S. aureus pneumonia was associated with HMGB1 release in the bronchoalveolar compartment peaking after 24 hours. Anti-HMGB1 attenuated lung pathology and protein leak and reduced interleukin-1β release 6 hours after infection, but not at later time points. RAGE deficiency more modestly attenuated lung pathology without influencing protein leak, while TLR4 deficiency did not impact on lung injury.

Conclusion

These data suggest that HMGB1 and RAGE, but not TLR4, contribute to lung injury accompanying the early phase of S. aureus pneumonia.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lowy FD: Staphylococcus aureus infections. N Engl J Med 1998, 339: 520-532. 10.1056/NEJM199808203390806CrossRefPubMed Lowy FD: Staphylococcus aureus infections. N Engl J Med 1998, 339: 520-532. 10.1056/NEJM199808203390806CrossRefPubMed
2.
go back to reference Boucher HW, Corey GR: Epidemiology of methicillin-resistant Staphylococcus aureus. Clin Infect Dis Official Pub Infect Dis Soc Am 2008, 46: S344-S349. 10.1086/533590CrossRef Boucher HW, Corey GR: Epidemiology of methicillin-resistant Staphylococcus aureus. Clin Infect Dis Official Pub Infect Dis Soc Am 2008, 46: S344-S349. 10.1086/533590CrossRef
3.
go back to reference Francis JS, Doherty MC, Lopatin U, Johnston CP, Sinha G, Ross T, Cai M, Hansel NN, Perl T, Ticehurst JR, Carroll K, Thomas DL, Nuermberger E, Bartlett JG: Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis Official Pub Infect Dis Soc Am 2005, 40: 100-107. 10.1086/427148CrossRef Francis JS, Doherty MC, Lopatin U, Johnston CP, Sinha G, Ross T, Cai M, Hansel NN, Perl T, Ticehurst JR, Carroll K, Thomas DL, Nuermberger E, Bartlett JG: Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis Official Pub Infect Dis Soc Am 2005, 40: 100-107. 10.1086/427148CrossRef
4.
go back to reference Parker D, Prince A: Immunopathogenesis of Staphylococcus aureus pulmonary infection. Seminars Immunopathol 2012, 34: 281-297. 10.1007/s00281-011-0291-7CrossRef Parker D, Prince A: Immunopathogenesis of Staphylococcus aureus pulmonary infection. Seminars Immunopathol 2012, 34: 281-297. 10.1007/s00281-011-0291-7CrossRef
5.
go back to reference Bartlett AH, Foster TJ, Hayashida A, Park PW: Alpha-toxin facilitates the generation of CXC chemokine gradients and stimulates neutrophil homing in Staphylococcus aureus pneumonia. J Infect Dis 2008, 198: 1529-1535. 10.1086/592758CrossRefPubMed Bartlett AH, Foster TJ, Hayashida A, Park PW: Alpha-toxin facilitates the generation of CXC chemokine gradients and stimulates neutrophil homing in Staphylococcus aureus pneumonia. J Infect Dis 2008, 198: 1529-1535. 10.1086/592758CrossRefPubMed
6.
go back to reference Craig A, Mai J, Cai S, Jeyaseelan S: Neutrophil recruitment to the lungs during bacterial pneumonia. Infect Immunity 2009, 77: 568-575. 10.1128/IAI.00832-08CrossRef Craig A, Mai J, Cai S, Jeyaseelan S: Neutrophil recruitment to the lungs during bacterial pneumonia. Infect Immunity 2009, 77: 568-575. 10.1128/IAI.00832-08CrossRef
7.
go back to reference Diep BA, Chan L, Tattevin P, Kajikawa O, Martin TR, Basuino L, Mai TT, Marbach H, Braughton KR, Whitney AR, Gardner DJ, Fan X, Tseng CW, Liu GY, Badiou C, Etienne J, Lina G, Matthay MA, DeLeo FR, Chambers HF: Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury. Proc Natl Acad Sci USA 2010, 107: 5587-5592. 10.1073/pnas.0912403107PubMedCentralCrossRefPubMed Diep BA, Chan L, Tattevin P, Kajikawa O, Martin TR, Basuino L, Mai TT, Marbach H, Braughton KR, Whitney AR, Gardner DJ, Fan X, Tseng CW, Liu GY, Badiou C, Etienne J, Lina G, Matthay MA, DeLeo FR, Chambers HF: Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury. Proc Natl Acad Sci USA 2010, 107: 5587-5592. 10.1073/pnas.0912403107PubMedCentralCrossRefPubMed
8.
go back to reference Bianchi ME: DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukocyte Biol 2007, 81: 1-5.CrossRefPubMed Bianchi ME: DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukocyte Biol 2007, 81: 1-5.CrossRefPubMed
9.
go back to reference Sims GP, Rowe DC, Rietdijk ST, Herbst R, Coyle AJ: HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol 2010, 28: 367-388. 10.1146/annurev.immunol.021908.132603CrossRefPubMed Sims GP, Rowe DC, Rietdijk ST, Herbst R, Coyle AJ: HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol 2010, 28: 367-388. 10.1146/annurev.immunol.021908.132603CrossRefPubMed
10.
go back to reference Yang H, Antoine DJ, Andersson U, Tracey KJ: The many faces of HMGB1: molecular structure-functional activity in inflammation, apoptosis, and chemotaxis. J Leukocyte Biol 2013, 93: 865-873. 10.1189/jlb.1212662PubMedCentralCrossRefPubMed Yang H, Antoine DJ, Andersson U, Tracey KJ: The many faces of HMGB1: molecular structure-functional activity in inflammation, apoptosis, and chemotaxis. J Leukocyte Biol 2013, 93: 865-873. 10.1189/jlb.1212662PubMedCentralCrossRefPubMed
11.
go back to reference Constien R, Forde A, Liliensiek B, Grone HJ, Nawroth P, Hammerling G, Arnold B: Characterization of a novel EGFP reporter mouse to monitor Cre recombination as demonstrated by a Tie2 Cre mouse line. Genesis 2001, 30: 36-44. 10.1002/gene.1030CrossRefPubMed Constien R, Forde A, Liliensiek B, Grone HJ, Nawroth P, Hammerling G, Arnold B: Characterization of a novel EGFP reporter mouse to monitor Cre recombination as demonstrated by a Tie2 Cre mouse line. Genesis 2001, 30: 36-44. 10.1002/gene.1030CrossRefPubMed
12.
go back to reference Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K, Akira S: Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 1999, 162: 3749-3752.PubMed Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K, Akira S: Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 1999, 162: 3749-3752.PubMed
13.
go back to reference Entezari M, Weiss DJ, Sitapara R, Whittaker L, Wargo MJ, Li J, Wang H, Yang H, Sharma L, Phan BD, Javdan M, Chavan SS, Miller EJ, Tracey KJ, Mantell LL: Inhibition of high-mobility group box 1 protein (HMGB1) enhances bacterial clearance and protects against Pseudomonas Aeruginosa pneumonia in cystic fibrosis. Mole Med 2012, 18: 477-485. Entezari M, Weiss DJ, Sitapara R, Whittaker L, Wargo MJ, Li J, Wang H, Yang H, Sharma L, Phan BD, Javdan M, Chavan SS, Miller EJ, Tracey KJ, Mantell LL: Inhibition of high-mobility group box 1 protein (HMGB1) enhances bacterial clearance and protects against Pseudomonas Aeruginosa pneumonia in cystic fibrosis. Mole Med 2012, 18: 477-485.
14.
go back to reference Rijneveld AW, Weijer S, Florquin S, Esmon CT, Meijers JC, Speelman P, Reitsma PH, Ten Cate H, van der Poll T: Thrombomodulin mutant mice with a strongly reduced capacity to generate activated protein C have an unaltered pulmonary immune response to respiratory pathogens and lipopolysaccharide. Blood 2004, 103: 1702-1709. 10.1182/blood-2002-05-1380CrossRefPubMed Rijneveld AW, Weijer S, Florquin S, Esmon CT, Meijers JC, Speelman P, Reitsma PH, Ten Cate H, van der Poll T: Thrombomodulin mutant mice with a strongly reduced capacity to generate activated protein C have an unaltered pulmonary immune response to respiratory pathogens and lipopolysaccharide. Blood 2004, 103: 1702-1709. 10.1182/blood-2002-05-1380CrossRefPubMed
15.
go back to reference Patel VS, Sitapara RA, Gore A, Phan B, Sharma L, Sampat V, Li JH, Yang H, Chavan SS, Wang H, Tracey KJ, Mantell LL: High mobility group box-1 mediates hyperoxia-Induced Impairment of pseudomonas aeruginosa clearance and inflammatory lung injury in mice. Am J Respiratory Cell Mole Biol 2013, 48: 280-287. 10.1165/rcmb.2012-0279OCCrossRef Patel VS, Sitapara RA, Gore A, Phan B, Sharma L, Sampat V, Li JH, Yang H, Chavan SS, Wang H, Tracey KJ, Mantell LL: High mobility group box-1 mediates hyperoxia-Induced Impairment of pseudomonas aeruginosa clearance and inflammatory lung injury in mice. Am J Respiratory Cell Mole Biol 2013, 48: 280-287. 10.1165/rcmb.2012-0279OCCrossRef
16.
go back to reference Abraham E, Arcaroli J, Carmody A, Wang H, Tracey KJ: HMG-1 as a mediator of acute lung inflammation. J Immunol 2000, 165: 2950-2954.CrossRefPubMed Abraham E, Arcaroli J, Carmody A, Wang H, Tracey KJ: HMG-1 as a mediator of acute lung inflammation. J Immunol 2000, 165: 2950-2954.CrossRefPubMed
17.
go back to reference Kim JY, Park JS, Strassheim D, Douglas I, Diaz del Valle F, Asehnoune K, Mitra S, Kwak SH, Yamada S, Maruyama I, Ishizaka A, Abraham E: HMGB1 contributes to the development of acute lung injury after hemorrhage. Am J Physiol Lung Cell Mole Physiol 2005, 288: L958-L965. 10.1152/ajplung.00359.2004CrossRef Kim JY, Park JS, Strassheim D, Douglas I, Diaz del Valle F, Asehnoune K, Mitra S, Kwak SH, Yamada S, Maruyama I, Ishizaka A, Abraham E: HMGB1 contributes to the development of acute lung injury after hemorrhage. Am J Physiol Lung Cell Mole Physiol 2005, 288: L958-L965. 10.1152/ajplung.00359.2004CrossRef
18.
go back to reference Ogawa EN, Ishizaka A, Tasaka S, Koh H, Ueno H, Amaya F, Ebina M, Yamada S, Funakoshi Y, Soejima J, Moriyama K, Kotani T, Hashimoto S, Morisaki H, Abraham E, Takeda : Contribution of high-mobility group box-1 to the development of ventilator-induced lung injury. Am J Respir Crit care Med 2006, 174: 400-407. 10.1164/rccm.200605-699OCCrossRefPubMed Ogawa EN, Ishizaka A, Tasaka S, Koh H, Ueno H, Amaya F, Ebina M, Yamada S, Funakoshi Y, Soejima J, Moriyama K, Kotani T, Hashimoto S, Morisaki H, Abraham E, Takeda : Contribution of high-mobility group box-1 to the development of ventilator-induced lung injury. Am J Respir Crit care Med 2006, 174: 400-407. 10.1164/rccm.200605-699OCCrossRefPubMed
19.
go back to reference Schierbeck H, Lundback P, Palmblad K, Klevenvall L, Erlandsson-Harris H, Andersson U, Ottosson L: Monoclonal anti-HMGB1 (high mobility group box chromosomal protein 1) antibody protection in two experimental arthritis models. Mole Med 2011, 17: 1039-1044. Schierbeck H, Lundback P, Palmblad K, Klevenvall L, Erlandsson-Harris H, Andersson U, Ottosson L: Monoclonal anti-HMGB1 (high mobility group box chromosomal protein 1) antibody protection in two experimental arthritis models. Mole Med 2011, 17: 1039-1044.
20.
go back to reference Sethi S, Chakraborty T: Role of TLR-/NLR-signaling and the associated cytokines involved in recruitment of neutrophils in murine models of Staphylococcus aureus infection. Virulence 2011, 2: 316-328. 10.4161/viru.2.4.16142CrossRefPubMed Sethi S, Chakraborty T: Role of TLR-/NLR-signaling and the associated cytokines involved in recruitment of neutrophils in murine models of Staphylococcus aureus infection. Virulence 2011, 2: 316-328. 10.4161/viru.2.4.16142CrossRefPubMed
21.
go back to reference van Zoelen MA, Yang H, Florquin S, Meijers JC, Akira S, Arnold B, Nawroth PP, Bierhaus A, Tracey KJ, van der Poll T: Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo . Shock 2009, 31: 280-284. 10.1097/SHK.0b013e318186262dPubMedCentralCrossRefPubMed van Zoelen MA, Yang H, Florquin S, Meijers JC, Akira S, Arnold B, Nawroth PP, Bierhaus A, Tracey KJ, van der Poll T: Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo . Shock 2009, 31: 280-284. 10.1097/SHK.0b013e318186262dPubMedCentralCrossRefPubMed
22.
go back to reference Kuipers MT, van der Poll T, Schultz MJ, Wieland CW: Bench-to-bedside review: Damage-associated molecular patterns in the onset of ventilator-induced lung injury. Crit Care 2011, 15: 235. 10.1186/cc10437PubMedCentralCrossRefPubMed Kuipers MT, van der Poll T, Schultz MJ, Wieland CW: Bench-to-bedside review: Damage-associated molecular patterns in the onset of ventilator-induced lung injury. Crit Care 2011, 15: 235. 10.1186/cc10437PubMedCentralCrossRefPubMed
23.
go back to reference Tsung A, Klune JR, Zhang X, Jeyabalan G, Cao Z, Peng X, Stolz DB, Geller DA, Rosengart MR, Billiar TR: HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling. J Exp Med 2007, 204: 2913-2923. 10.1084/jem.20070247PubMedCentralCrossRefPubMed Tsung A, Klune JR, Zhang X, Jeyabalan G, Cao Z, Peng X, Stolz DB, Geller DA, Rosengart MR, Billiar TR: HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling. J Exp Med 2007, 204: 2913-2923. 10.1084/jem.20070247PubMedCentralCrossRefPubMed
24.
go back to reference Levy RM, Mollen KP, Prince JM, Kaczorowski DJ, Vallabhaneni R, Liu S, Tracey KJ, Lotze MT, Hackam DJ, Fink MP, Vodovotz Y, Billiar TR: Systemic inflammation and remote organ injury following trauma require HMGB1. Am J Physiol Regulatory Integr Compar Physiol 2007, 293: R1538-R1544. 10.1152/ajpregu.00272.2007CrossRef Levy RM, Mollen KP, Prince JM, Kaczorowski DJ, Vallabhaneni R, Liu S, Tracey KJ, Lotze MT, Hackam DJ, Fink MP, Vodovotz Y, Billiar TR: Systemic inflammation and remote organ injury following trauma require HMGB1. Am J Physiol Regulatory Integr Compar Physiol 2007, 293: R1538-R1544. 10.1152/ajpregu.00272.2007CrossRef
25.
go back to reference Zhang X, Shan P, Qureshi S, Homer R, Medzhitov R, Noble PW, Lee PJ: Cutting edge: TLR4 deficiency confers susceptibility to lethal oxidant lung injury. J Immunol 2005, 175: 4834-4838.CrossRefPubMed Zhang X, Shan P, Qureshi S, Homer R, Medzhitov R, Noble PW, Lee PJ: Cutting edge: TLR4 deficiency confers susceptibility to lethal oxidant lung injury. J Immunol 2005, 175: 4834-4838.CrossRefPubMed
26.
go back to reference Ogawa Y, Tasaka S, Yamada W, Saito F, Hasegawa N, Miyasho T, Ishizaka A: Role of Toll-like receptor 4 in hyperoxia-induced lung inflammation in mice. Inflam Res Official J Euro Histamine Res Soc 2007, 56: 334-338. Ogawa Y, Tasaka S, Yamada W, Saito F, Hasegawa N, Miyasho T, Ishizaka A: Role of Toll-like receptor 4 in hyperoxia-induced lung inflammation in mice. Inflam Res Official J Euro Histamine Res Soc 2007, 56: 334-338.
27.
go back to reference Reynolds PR, Schmitt RE, Kasteler SD, Sturrock A, Sanders K, Bierhaus A, Nawroth PP, Paine R 3rd, Hoidal JR: Receptors for advanced glycation end-products targeting protect against hyperoxia-induced lung injury in mice. Am J Respir Cell Mole Biol 2010, 42: 545-551. 10.1165/rcmb.2008-0265OCCrossRef Reynolds PR, Schmitt RE, Kasteler SD, Sturrock A, Sanders K, Bierhaus A, Nawroth PP, Paine R 3rd, Hoidal JR: Receptors for advanced glycation end-products targeting protect against hyperoxia-induced lung injury in mice. Am J Respir Cell Mole Biol 2010, 42: 545-551. 10.1165/rcmb.2008-0265OCCrossRef
28.
go back to reference He M, Kubo H, Ishizawa K, Hegab AE, Yamamoto Y, Yamamoto H, Yamaya M: The role of the receptor for advanced glycation end-products in lung fibrosis. Am J Physiol Lung Cell Mole Physiol 2007, 293: L1427-L1436. 10.1152/ajplung.00075.2007CrossRef He M, Kubo H, Ishizawa K, Hegab AE, Yamamoto Y, Yamamoto H, Yamaya M: The role of the receptor for advanced glycation end-products in lung fibrosis. Am J Physiol Lung Cell Mole Physiol 2007, 293: L1427-L1436. 10.1152/ajplung.00075.2007CrossRef
29.
go back to reference van Zoelen MA, Schouten M, de Vos AF, Florquin S, Meijers JC, Nawroth PP, Bierhaus A, van der Poll T: The receptor for advanced glycation end products impairs host defense in pneumococcal pneumonia. J Immunol 2009, 182: 4349-4356. 10.4049/jimmunol.0801199CrossRefPubMed van Zoelen MA, Schouten M, de Vos AF, Florquin S, Meijers JC, Nawroth PP, Bierhaus A, van der Poll T: The receptor for advanced glycation end products impairs host defense in pneumococcal pneumonia. J Immunol 2009, 182: 4349-4356. 10.4049/jimmunol.0801199CrossRefPubMed
Metadata
Title
High-mobility group box 1 and the receptor for advanced glycation end products contribute to lung injury during Staphylococcus aureus pneumonia
Authors
Ahmed Achouiti
Anne Jan van der Meer
Sandrine Florquin
Huan Yang
Kevin J Tracey
Cornelis van ’t Veer
Alex F de Vos
Tom van der Poll
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Critical Care / Issue 6/2013
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc13162

Other articles of this Issue 6/2013

Critical Care 6/2013 Go to the issue